1. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? 
Kevin M Harris, MD, Thoralf M Sundt, MD, Dorothy Aeppli, PhD, Rajesh Sharma, MD, Benico Barzilai, MD 
The Annals of Thoracic Surgery 
Volume 74, Issue 5, Pages (November 2002)
DOI: /S (02)

2. Fig 1
Actuarial survival for patients with moderate mitral regurgitation undergoing coronary artery bypass surgery (CAB) with and without valve repair or replacement. Actuarial survival curve is shown for patients with moderate mitral regurgitation undergoing CAB or CAB plus mitral repair or replacement (CAB/MVR). Survival is similar (p = NS). Data regarding late survival were obtained for 97% of the study group. Five patients were lost to follow-up as of May 1, 1998, with 2 of them being alive at last follow-up date. The mean follow-up for the CAB alone group was 5.1 ± 0.3 (range 0 to 9) years and that for the combined procedure group was 4.7 ± 0.6 (range 0 to 8.1) years (p = NS).
The Annals of Thoracic Surgery  , DOI: ( /S (02) )

3. Fig 2
Actuarial survival in patients with moderate MR undergoing CAB or CAB + MVR stratified by NYHA class. Survival for the two groups for patients undergoing CAB or CAB + MVR is stratified by NYHA classification (p = 0.005). (CAB = coronary artery bypass; MR = mitral regurgitation; MVR = mitral valve repair or replacement; NYHA = New York Heart Association.)
The Annals of Thoracic Surgery  , DOI: ( /S (02) )